FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3045112147> ?p ?o ?g. }

• W3045112147 endingPage "1782" @default.
• W3045112147 startingPage "1772" @default.
• W3045112147 abstract "OBJECTIVE Glioma stem cells (GSCs) are responsible for tumor initiation, therapeutic resistance, and recurrence. CD146 is mainly expressed in dividing GSCs and regulates cell cycle progression. However, the evaluation of the efficacy of targeted therapy against CD146 in vivo remains to be investigated. In this study, the authors aimed to develop gene therapy targeting GSCs using chitosan oligosaccharide lactate (COL) nanoparticles (NPs) conjugated with folic acid–polyethylene glycol (FA-PEG-COL NPs) for in vitro and in vivo delivery of CD146 small-interfering RNA (siCD146) and to determine the effect of CD146 knockdown on tumor growth. METHODS To examine the uptake of NPs by tumor cells, immunofluorescence staining, flow cytometry, and in vivo imaging were performed. The knockdown effect of siCD146 was measured by western blot and water-soluble tetrazolium salt–8 assay in mouse glioma cells. The efficacy of siRNA therapy–targeted GSCs was evaluated by monitoring tumor growth through in vivo imaging and histological analysis. RESULTS In vivo accumulation of the FA-PEG-COL NPs in subcutaneous and intracranial gliomas following NP administration via a mouse tail vein was observed. Additionally, in vitro delivery of siCD146 ionically cross-linked NPs, reduced CD146 levels, and suppressed growth in the glioma tumor sphere. Evaluation of the in vivo therapeutic effects of siCD146–cross-linked NPs in a mouse glioma model revealed significant suppression of intracranial tumor growth, with complete removal of the tumor observed in some mice on histological examination. Furthermore, delivery of siCD146 significantly reduced the Ki-67 index in residual tumor tissues relative to that in control mice. CONCLUSIONS CD146 is a potential therapeutic target, and folic acid–conjugated NPs delivering siRNA may facilitate gene therapy in malignant gliomas." @default.
• W3045112147 created "2020-07-29" @default.
• W3045112147 creator A5004925326 @default.
• W3045112147 creator A5030242147 @default.
• W3045112147 creator A5034249302 @default.
• W3045112147 creator A5043392299 @default.
• W3045112147 creator A5052701519 @default.
• W3045112147 creator A5055915838 @default.
• W3045112147 creator A5060134247 @default.
• W3045112147 creator A5069882972 @default.
• W3045112147 creator A5078795928 @default.
• W3045112147 date "2021-06-01" @default.
• W3045112147 modified "2023-10-14" @default.
• W3045112147 title "Targeting CD146 using folic acid–conjugated nanoparticles and suppression of tumor growth in a mouse glioma model" @default.
• W3045112147 cites W1523297072 @default.
• W3045112147 cites W1877301297 @default.
• W3045112147 cites W1928584722 @default.
• W3045112147 cites W1972669392 @default.
• W3045112147 cites W1983800816 @default.
• W3045112147 cites W1989165356 @default.
• W3045112147 cites W1992792489 @default.
• W3045112147 cites W1997632957 @default.
• W3045112147 cites W2010234254 @default.
• W3045112147 cites W2024672608 @default.
• W3045112147 cites W2027629777 @default.
• W3045112147 cites W2029470215 @default.
• W3045112147 cites W2033022462 @default.
• W3045112147 cites W2041617965 @default.
• W3045112147 cites W2054064131 @default.
• W3045112147 cites W2054157163 @default.
• W3045112147 cites W2061076135 @default.
• W3045112147 cites W2080983211 @default.
• W3045112147 cites W2086914247 @default.
• W3045112147 cites W2108973415 @default.
• W3045112147 cites W2113942802 @default.
• W3045112147 cites W2127498080 @default.
• W3045112147 cites W2128469603 @default.
• W3045112147 cites W2152387543 @default.
• W3045112147 cites W2161289668 @default.
• W3045112147 cites W2161333480 @default.
• W3045112147 cites W2314360422 @default.
• W3045112147 cites W2397198015 @default.
• W3045112147 cites W2538437447 @default.
• W3045112147 cites W2594836892 @default.
• W3045112147 cites W2607167117 @default.
• W3045112147 cites W2946313598 @default.
• W3045112147 cites W2946956363 @default.
• W3045112147 doi "https://doi.org/10.3171/2020.4.jns193078" @default.
• W3045112147 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32707539" @default.
• W3045112147 hasPublicationYear "2021" @default.
• W3045112147 type Work @default.
• W3045112147 sameAs 3045112147 @default.
• W3045112147 citedByCount "5" @default.
• W3045112147 countsByYear W30451121472022 @default.
• W3045112147 countsByYear W30451121472023 @default.
• W3045112147 crossrefType "journal-article" @default.
• W3045112147 hasAuthorship W3045112147A5004925326 @default.
• W3045112147 hasAuthorship W3045112147A5030242147 @default.
• W3045112147 hasAuthorship W3045112147A5034249302 @default.
• W3045112147 hasAuthorship W3045112147A5043392299 @default.
• W3045112147 hasAuthorship W3045112147A5052701519 @default.
• W3045112147 hasAuthorship W3045112147A5055915838 @default.
• W3045112147 hasAuthorship W3045112147A5060134247 @default.
• W3045112147 hasAuthorship W3045112147A5069882972 @default.
• W3045112147 hasAuthorship W3045112147A5078795928 @default.
• W3045112147 hasBestOaLocation W30451121471 @default.
• W3045112147 hasConcept C10205521 @default.
• W3045112147 hasConcept C142724271 @default.
• W3045112147 hasConcept C150903083 @default.
• W3045112147 hasConcept C153911025 @default.
• W3045112147 hasConcept C203014093 @default.
• W3045112147 hasConcept C207001950 @default.
• W3045112147 hasConcept C2778227246 @default.
• W3045112147 hasConcept C2779093498 @default.
• W3045112147 hasConcept C28328180 @default.
• W3045112147 hasConcept C502942594 @default.
• W3045112147 hasConcept C553184892 @default.
• W3045112147 hasConcept C71924100 @default.
• W3045112147 hasConcept C86803240 @default.
• W3045112147 hasConcept C95444343 @default.
• W3045112147 hasConceptScore W3045112147C10205521 @default.
• W3045112147 hasConceptScore W3045112147C142724271 @default.
• W3045112147 hasConceptScore W3045112147C150903083 @default.
• W3045112147 hasConceptScore W3045112147C153911025 @default.
• W3045112147 hasConceptScore W3045112147C203014093 @default.
• W3045112147 hasConceptScore W3045112147C207001950 @default.
• W3045112147 hasConceptScore W3045112147C2778227246 @default.
• W3045112147 hasConceptScore W3045112147C2779093498 @default.
• W3045112147 hasConceptScore W3045112147C28328180 @default.
• W3045112147 hasConceptScore W3045112147C502942594 @default.
• W3045112147 hasConceptScore W3045112147C553184892 @default.
• W3045112147 hasConceptScore W3045112147C71924100 @default.
• W3045112147 hasConceptScore W3045112147C86803240 @default.
• W3045112147 hasConceptScore W3045112147C95444343 @default.
• W3045112147 hasIssue "6" @default.
• W3045112147 hasLocation W30451121471 @default.
• W3045112147 hasLocation W30451121472 @default.
• W3045112147 hasOpenAccess W3045112147 @default.

• next